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ABSTRACT 
This study aimed to identify self-report correlates of central pain augmentation in 
individuals with knee pain. A subset of participants (n=420) in the Knee Pain and related 
health In the Community (KPIC) baseline survey undertook pressure pain threshold (PPT) 
assessments. Items measuring specific traits related to central pain mechanisms were 
selected from the survey based on expert consensus, face validity, item association to 
underlying constructs measured by originating host questionnaires, adequate targeting and 
PPT correlations. Pain distribution was reported on a body manikin.  A `central pain 
mechanisms’ factor was sought by factor analysis. Associations of items, the derived factor 
and originating questionnaires with PPTs were compared. Eight self-report items measuring 
traits of anxiety, depression, catastrophizing, neuropathic- like pain, fatigue, sleep 
disturbance, pain distribution and cognitive impact, were identified as likely indices of 
central pain mechanisms. PPTs were associated with items representing each trait and with 
their originating scales. Pain distribution classified as “pain below the waist additional to 
knee pain” was more strongly associated with low PPT than were alternative classifications 
of pain distribution. A single factor, interpreted as “central pain mechanisms”, was 
identified across the 8 selected items and explained variation in PPT (R2 = 0.17) better than 
did any originating scale (R2 = 0.10 to 0.13). In conclusion, including representative items 
within a composite self-report tool might help identify people with centrally augmented 
knee pain. 
Keywords: Knee Pain, Phenotypes, central mechanisms, Quantitative Sensory Testing 
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INTRODUCTION 1 
Knee pain is a major source of disability, and in people aged over 50 years is most commonly 2 
attributed to osteoarthritis (OA).60 OA pain is perceived as originating from the joint, often 3 
associated with structural changes or inflammation, and exacerbated by joint loading and 4 
movement. However, OA pain is often troublesome even in the absence of severe 5 
radiographic change,24 and might persist after removal of the peripheral nociceptive drive, 6 
with persistent pain being reported by 10-20% of people following total knee replacement 7 
for knee OA.4, 79, 80 Evidence from mechanistic (i.e., experimental pain testing and functional 8 
neuroimaging studies)25, 30, 33, 59, 60, 69 and therapeutic trials,11, 29 indicate that the central 9 
nervous system (CNS) might amplify neural signalling and influence OA knee pain sensitivity, 10 
leading to central pain augmentation.42, 78 Optimal management of OA knee pain therefore 11 
requires that underlying pain mechanisms be identified in each individual.3 12 
Quantitative Sensory Testing (QST) can indicate changes in pain sensitivity. Pressure pain 13 
detection thresholds (PPT) might be reduced at a site of clinical pain, suggesting neuronal 14 
sensitization of the affected area. More widespread increased sensitivity at pain-free control 15 
sites is suggestive of altered pain processing in the central nervous system.16, 31 In animal 16 
models of OA, pain sensitivity (reduced withdrawal thresholds to punctate stimulation) at a 17 
site distal to the affected knee (hindpaw) is characterized by spinal hyperexcitability of 18 
neurons innervating sites distal to the affected joint.23, 56, 63, 64 Furthermore, pain sensitivity 19 
distal to the affected joint in people with OA has been associated with changes to 20 
descending pain control mechanisms,33 as has more widespread pain in people with 21 
fibromyalgia.5  22 
Individual differences in distinct observable traits (phenotypes), measured by 23 
questionnaires addressing depression, anxiety, catastrophizing, neuropathic- like pain, or 24 
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widespread pain (WSP), have been associated with knee pain severity.10, 16, 35, 39, 62, 67, 68 Each 1 
of these traits might also be associated with markers of central pain mechanisms.6, 7, 36, 45, 46, 2 
49, 51, 62, 71  High scores on these questionnaires, and low PPTs, have each predicted poor 3 
outcome following treatment directed to the painful joint,2, 59, 60, 79, 80 raising the possibility 4 
that treatments directed to central pain mechanisms might be useful for those patients. 5 
Using a full battery of existing questionnaires plus PPT measurement would be resource-6 
intensive during normal clinical encounters. A concise composite self-report tool is needed 7 
to help identify people with centrally augmented knee pain. 8 
We hypothesise that each of these traits might reflect aspects of central pain mechanisms. 9 
By combining evidence from expert opinion and statistical analysis of questionnaire data 10 
from a community-based study in people with knee pain, we aimed to identify a concise, yet 11 
psychometrically reliable and valid set of self-report questions that measure a phenotypic 12 
trait associated with central pain augmentation, as indicated by reduced PPT at the proximal 13 
tibia, a site distal to the painful knee. 14 
METHODS 15 
Study Population 16 
Participants, aged ≥40 years provided baseline data within the Nottinghamshire community-17 
based Knee Pain and Related Health in the Community study (KPIC) cohort study.22  18 
Questionnaires factor structure was confirmed using data from 2,512 participants who 19 
reported current knee pain (61 ± 10 years, 57% female). A purposive subset of KPIC 20 
participants (n=420) underwent further clinical, PPT and radiographic assessments.22 This 21 
subset comprised people with no knee pain (n=98), or pain for <3 years (n=219) or >3 years 22 
(n=103). The KPIC study protocol (clinicaltrials.gov portal: NCT02098070) was approved by 23 
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the Nottingham Research Ethics Committee 1 (NREC Ref: 14/EM/0015) and all participants 1 
provided informed written consent. 2 
Self-report questionnaires 3 
Presence of current knee pain was determined by response to the question: “Have you had 4 
knee pain for most days of the past one month?”61, 74 5 
Participants reporting knee pain indicated the affected knee if unilateral, or the worst 6 
affected knee if bilateral. 7 
The KPIC baseline survey included established self-report questionnaires for neuropathic- 8 
like pain (painDETECT modified for use in people with knee OA),39 intermittent and constant 9 
osteoarthritis knee pain (ICOAP),37 catastrophic thinking (Pain Catastrophizing Scale, PCS),72 10 
and anxiety and depression (Hospital Anxiety and Depression Scale, HADS).81 Traits of 11 
fatigue, cognitive impact,65 and pain distribution,40 were each measured by single items. 12 
Rasch‐transformed questionnaire scores were used when previously validated in knee pain 13 
cases (painDETECT, ICOAP),37, 39 otherwise non-transformed scores were used (HADS, PCS). 14 
Items were coded so that higher scores represented greater pain or distress. 15 
Pain distribution was captured using areas shaded by the participant on a body manikin. The 16 
manikin was coded according to shading in 7-and 25- topographical areas.15, 77 Pain 17 
distribution was also categorized using American College of Rheumatology Widespread Pain 18 
(ACR’s WSP) criteria,77 and based on the presence or absence of pain (i) contralateral to the 19 
index knee, (ii) above the waist, (iii) below the waist, or (iv) axial.  20 
Pressure pain detection thresholds  21 
PPT was measured using a hand-held pressure algometer with a circular (1cm2) padded-22 
tipped probe connected to a computer (HP ProBook 4520s), with outputs computer 23 
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analysed by dedicated software (Somedic AB, Sweden). Pressure was applied with a 1 
standardised 30kPa/s ramp until the participant indicated by pressing a button, a change 2 
from pressure to pain sensation. Participants were familiarised prior to testing by twice PPT 3 
testing on a fingernail of the dominant hand. Each PPT testing cycle was conducted at the 4 
sternum (3cm caudal to the sternal notch), the medial and lateral tibiofemoral joint lines 5 
adjacent to the patellar ligament of each knee, and the proximal tibia (5 cm distal to the 6 
tibial tuberosity of each leg). The PPT cycle was repeated three times with a 2 minute rest 7 
period between each cycle. PPT values (kPA) for each site were averaged across the 3 cycles. 8 
PPT assessments for each participant was undertaken using a standardized protocol by one 9 
of two trained researchers, blinded to participant characteristics including pain status.22 10 
Raw PPT values were not normally distributed, thus PPTs were logarithmically transformed 11 
before statistical analysis to achieve normality of the data, and normality confirmed using 12 
the Shapiro-Wilk test.  13 
PPT values served as a reference test during Receiver Operating Curve (ROC) analysis to 14 
identify the number of painful sites other than the knee, reported on the body pain manikin 15 
that is indicative of central pain mechanisms. Preliminary analysis demonstrated no 16 
significant differences in PPT between participants with or without knee pain, and 17 
therefore, standardized z-scores were computed from log PPT data for all 420 participants. 18 
PPT values below the 10th percentile (z >1.28) were classified as abnormally increased 19 
sensitivity (gain-of-function) at the measured site.14 Number of painful sites were selected 20 
that maximized sensitivity while maintaining a minimum specificity of 0.75 for predicting 21 
PPT gain-of-function.54  22 
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Unless otherwise stated, results are reported in the main text for primary analyses using 1 
PPTs (following log-transformation) at the proximal tibia distal to the participant’s worst 2 
affected knee, taken to be an index for centrally augmented pain.73 Results for secondary 3 
analyses using PPT measured at other sites are reported within the supplementary tables. 4 
Item selection 5 
We used a sequential strategy to select items representing traits reflecting central pain 6 
mechanisms (Figure 1):  7 
(1) Items not relevant to the study hypothesis were excluded, following initial screening by 8 
the research team. 9 
(2) Where items originated from established questionnaires (PCS, HADS, painDETECT, and 10 
ICOAP), the 2 items were selected with highest loading to each questionnaire’s latent 11 
constructs. Item loading was determined by exploratory Structural Equation Modelling 12 
(ESEM)18 across each questionnaire, using data from KPIC participants who reported current 13 
knee pain (n=2152). 14 
(3) Items were excluded if there was below moderate expert agreement (k*<0.60) on their 15 
relevance to central mechanisms of knee pain.12, 27 Invited experts comprised experienced 16 
clinical and research experts (n = 25) across various pain research disciplines (orthopaedics, 17 
rheumatology, sports and exercise medicine, psychology, neuroscience, physiotherapy, 18 
pharmacy, genetics and musculoskeletal epidemiology) within the Arthritis Research UK 19 
(ARUK) Pain Centre. Experts indicated relevance for each item using a four-point Likert scale 20 
(0 “not relevant” to 3 “highly relevant”).  21 
(4) The percentage of respondents selecting each response category for an item was 22 
examined in order to ensure adequate targeting (a balanced frequency (%) of selection for 23 
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each response category provided for an item across a study population). Items were 1 
excluded if any single response category was selected by ≥80% of participants.8, 47 2 
(5) Items were excluded if associations with PPT at the proximal tibia were not statistically 3 
significant. PPT at the proximal tibia (an unaffected site, distal to the affected knee) was 4 
taken to be indicative of central pain mechanisms.73 Lack of a relationship between a self-5 
report item and PPT was taken to indicate that the item might itself, not be indicative of 6 
central pain mechanisms. 7 
---------------------------------------------Insert Figure 1 (Flow chart) --------------------------------- 8 
 9 
Data Analysis  10 
PPT homogeneity was assessed using concordance correlation coefficient (CCC) to establish 11 
intra- and inter-rater agreement for the 2 PPT assessors.43 12 
Associations between PPT and questionnaire data in participants with knee pain (n=322) are 13 
presented as Spearman’s correlation coefficients (r) or standardized regression coefficients 14 
(β) from linear regression models. Adjusted p values were obtained using Bonferroni 15 
correction. All analyses utilised complete case data due to low levels of missing data.  16 
Validation of selected items 17 
For factor analysis of the selected items, participants with knee pain who had undergone 18 
PPT assessment (n=322) were randomly allocated into two equal groups using Stata, version 19 
14.2,70 in order to avoid spurious or chance effects.28 Exploratory Structural Equation 20 
Modelling (ESEM) was used with one group and the resulting model was tested in the other 21 
group using confirmatory factor analysis (CFA). PPT variance explained by the identified 22 
factor(s) in fully adjusted models (Adjusted for age, sex and BMI), were compared with the 23 
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variance explained by the host scales. To explore equivalence of the identified factor(s) and 1 
selected items with respect to age, sex and BMI, Multiple-Indicator Multiple-Causal (MIMIC) 2 
models were employed. MIMIC models are a type of CFA model where the latent factors 3 
and the items are simultaneously regressed on to demographics and other relevant 4 
covariates.57  5 
We further sought to determine whether traits represented by the host scale explained the 6 
associations between PPT and items selected from that scale. Derived scale scores for each 7 
host scale were calculated by subtracting ‘the score for each selected item’ from ‘the 8 
summary score for the respective host scale’. Each model testing the association between 9 
PPT and a selected item, or between PPT and any identified factor(s), was adjusted for 10 
derived scale scores.  11 
Analyses were performed using Stata, version 14.2,70 except that ESEM and CFA used MPlus, 12 
version 7.4.52 Except where stated, all analyses were conducted within the participant group 13 
that reported knee pain and who had undergone PPT assessment (n=322). Demographics 14 
are presented as mean (SD) or median (Interquartile Range). Between-group comparisons 15 
used Student’s t test and, where appropriate, 95% Confidence Intervals (CIs) are presented. 16 
RESULTS 17 
Study Population 18 
The 322 participants with knee pain were on average 59 (SD 10) years of age, had an 19 
average BMI of 29 (SD 7), and most were female (61%). Participants without knee pain 20 
(n=98, 60% female, age 60±10 y) displayed geometric mean PPT at the proximal tibia of 383 21 
(95% CI 169 to 780) kPA, similar to those with knee pain (358 (95% CI 134 to 871) kPa, 22 
p=0.27). 23 
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Demographic and clinical characteristics for the knee pain group are presented in Table 1.  1 
-----------------------------------------------------Insert Table 1-------------------------------------------- 2 
Pressure pain detection thresholds 3 
PPTs at the proximal tibia displayed moderate inter-rater reliability (CCC = 0.51) and intra-4 
rater reliability (CCC = 0.60) (Supplementary Table 1). Lower PPTs were associated with 5 
female sex (females; 314 (287 to 343) kPa, males; 428 (391 to 473) kPa, p<0.0001) and 6 
higher BMI (r = -0.19, P = 0.002), but not with age (r = -0.01, P = 0.83). For those with knee 7 
pain, PPT was not associated with radiographic x-ray scores (r = -0.041, p = 0.491), but was 8 
associated with a painDETECT measure of knee pain severity (“How would you rate your 9 
most painful knee pain on a 0-10 scale at the present time, that is right now”) (r=-0.18, 10 
p=0.002). Pain severity showed a weak but significant relationship with radiographic scores 11 
(r = 0.15, p = 0.007). 12 
Pain distribution  13 
The number of other sites reported as painful in addition to knee pain was negatively 14 
correlated with PPT distal to the index knee (23 other sites: r =-0.16, p=0.008; 7 other sites: r 15 
=-0.16, p=0.007). Cut off points of ≥5/7 or ≥6/23 painful sites additional to knee, optimally 16 
predicted low PPT (specificity >0.75, accuracy 73.4%). `Knee pain plus other pain below the 17 
waist' showed significant association with PPT (β=-0.14; p<0.02), but other pain distribution 18 
categories did not (Table 2). ACR widespread pain classification did not significantly predict 19 
PPT, whether including (β = -0.03, p=0.55) or excluding (β= -0.05; p=0.37) knees as painful 20 
sites. The presence of “knee pain plus other pain below the waist” was selected for further 21 
analyses over `number of sites’ criteria due to ease of application. 22 
-----------------------------------------------------Insert Table 2-------------------------------------------- 23 
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Item Selection 1 
Twenty-five items potentially reflecting central mechanisms were selected for expert 2 
review. ESEM confirmed 11 latent factors from 4 questionnaires, representing anxiety or 3 
depression (HADS), magnification or rumination (PCS), pain intensity, evoked or 4 
spontaneous neuropathic-like pain (painDETECT), psychological or somatic effects of pain 5 
(both in each of the ICOAP Constant and Intermittent ICOAP subscales)(Supplementary 6 
Tables 2 to 6). Two items were selected with highest loading to each of these factors. 7 
Additional items measured traits of fatigue, cognitive impact, and pain distribution (pain 8 
manikin). Sixteen (64%) experts responded to the consensus task, and displayed moderate 9 
to excellent agreement (k>0.6) for relevance of 19 of the 25 items to central pain 10 
mechanisms (Table 3). 11 
Supplementary Table 7 gives item response distributions in people with knee pain. Each 12 
scale was positively associated with scores on other scales (r=0.23 to 0.63, p<0.05, 13 
Supplementary Table 8). The 19 items selected after expert review also all displayed 14 
significant positive associations with each other (r=0.07 to 0.87, Supplementary Table 9). 15 
Items from the intermittent ICOAP subscale showed strong correlations (r>0.8, p <0.05) with 16 
corresponding constant ICOAP items. 17 
Association between PPT and self-report scales or items 18 
Each scale was negatively associated at a univariate level with PPT (β= -0.09 to -0.21, each 19 
p<0.05 except intermittent-ICOAP, p=0.13). A significant proportion of variation in PPT was 20 
explained by each scale alone (R2 values = 0.10 to 0.13, p<0.05). Individual items displayed 21 
negative associations with PPT (Table 3). After excluding intermittent pain (to avoid item 22 
redundancy), a single item was selected to represent each of 8 remaining traits; fatigue, 23 
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cognitive impact, pain distribution, anxiety, depression, catastrophic thinking, neuropathic-1 
like, and constant pain (Table 3). 2 
-----------------------------------------------------Insert Table 3-------------------------------------------- 3 
Validation of selected items 4 
The 8 selected items displayed a Cronbach’s alpha (α) of 0.80, and predicted proximal tibia 5 
PPT in a multiple regression model (R2 = 0.18, p<0.05) more than did any trait specific scale 6 
or item. Competing 2- and 3- factor models for these items were not identified in the 7 
exploratory group and a specified 2-factor CFA models did not significantly alter the one-8 
factor model, supporting the one-factor model. The one-factor model also showing the best 9 
fit to data from the Confirmatory group (RMSEA = 0.07; WRMR = 0.5; X2(df) = 43(20)). Each 10 
item was significantly associated with the single latent construct, interpreted as 11 
representing central mechanisms of knee pain (Table 4).  12 
-----------------------------------------------------Insert Table 4-------------------------------------------- 13 
 14 
The latent construct was associated with PPT (β=-0.27; SE = 0.07; p<0.001), independent of 15 
each scale from which items were derived (Table 5). Associations between each selected 16 
item and PPT were reduced and lacked significance after adjusting for derived host scale 17 
scores (Supplementary Table 10), except for the neuropathic item on cold or heat on the 18 
area causing pain (β= -0.21, SE = 0.08, p <0.05) and the anxiety item “I get sudden feelings of 19 
panic” (β= -0.19, SE = 0.09, p <0.05), where the relationship remained significant after 20 
adjusting for derived host scale scores.  21 
The latent construct explained a higher proportion of PPT variance at the proximal tibia (R2 = 22 
0.17, SE = 0.05, p<0.001), compared to that explained by any multi-item, trait-specific 23 
questionnaire (R2 values = 0.10 to 0.13, p<0.05).  The latent construct also explained a high 24 
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proportion of PPT variance at the sternum (R2 = 0.20, SE = 0.05, p<0.001), medial- (R2 = 0.34, 1 
SE = 0.05, p<0.001) and lateral- (R2 = 0.24, SE = 0.05; p<0.001) joint line. The latent construct 2 
was also associated with knee pain severity (β =0.66; S.E. = 0.05, p<0.001), but not 3 
radiographic scores (β=0.10; SE=0.07; p=0.160). The relationship between the latent 4 
construct and PPT remained significant even when radiographic scores, or pain severity, 5 
were accounted for within the model (β=-0.267; SE=0.07; p<0.001, and β=-0.213; SE=0.06; 6 
p<0.001, respectively).  7 
 8 
-----------------------------------------------------Insert Table 5-------------------------------------------- 9 
The final best fitting MIMIC model was a good fit to the data (CFI = 0.943, TLI = 0.924; 10 
RMSEA = 0.050; WRMR = 0.761; x2(df) = 53.696 (33)). An effect of BMI on the latent 11 
construct (β=0.310, SE=0.064, p<0.001), but not gender (β=0.073, SE=0.070, p=0.295) nor 12 
age (β=-0.064, SE=0.069, p=0.357), was observed. Item specific effects for age (anxiety item: 13 
β =-0.114, SE=0.055, p=0.038) and BMI (depression item: β =0.135, SE=0.056, p=0.015) were 14 
observed, but not for gender. 15 
All secondary analyses using PPT at the index knee joint line or sternum produced similar 16 
results to those using proximal tibia PPT (Supplementary Tables 11 and 12). 17 
 18 
DISCUSSION 19 
In the current study, we identified 8 key traits, represented by 8 self-report items which 20 
together load onto a single construct interpreted as reflecting central pain mechanisms in 21 
people with knee pain. The 8 key traits were anxiety, depression, catastrophizing, 22 
neuropathic-like pain, fatigue, sleep disturbance, pain distribution and cognitive impact. 23 
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Items representative of these traits displayed high face validity based on expert opinion and 1 
external validity by association with high pain sensitivity (low PPT) at a site distal to the 2 
index knee, indicative of central sensitization.31 These items might identify people whose 3 
knee pain could benefit from treatments directed towards central mechanisms. 4 
Consistent with prior studies, we show that in individuals with knee pain, associations exist 5 
between reduced PPTs and increased scores on each of the eight traits.7, 30, 45 Scores for 6 
each trait were significantly correlated with the other traits, consistent with a single latent 7 
construct, but a combination of the 8 traits explained more variation in PPTs compared to 8 
any originating questionnaire alone. We conclude that a combination of items from across 9 
these 8 traits might indicate the extent of central pain augmentation in people with knee 10 
pain. Consistent with previous reports where between 5% - 20% of PPT variance was 11 
explained by demographic, psychological and/or genetic variables,19, 76 the latent construct 12 
explains a significant proportion of PPT variance. This provides evidence of validity as a 13 
model of central sensitisation, but further research would be required to determine 14 
whether the identified construct explains a greater proportion of variation in other indices 15 
of central sensitisation, or variation in pain relief in response to interventions that target 16 
central sensitisation in people with knee pain.66  17 
Augmented central pain processing is well recognised in people with chronic widespread 18 
pain (WSP), but can be more difficult to identify when pain is focussed on a specific 19 
anatomical site such as the knee. Further research might define whether the traits identified 20 
in the current study of people with knee pain, might also reflect augmented central pain 21 
processing in people with pain at another site. Several items identified in this study 22 
represent the emotional component of pain, and shared mechanisms within the central 23 
nervous system might underpin associations with central pain augmentation.48, 71 Cognitive 24 
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difficulties or `brain fog’ are frequent complaints of people with musculoskeletal pain,50 and 1 
experimental pain impairs performance in cognitive tasks.20, 75 Neuropathic-like pain is also 2 
prevalent in people reporting knee OA pain and has been associated with reduced PPTs.39, 49 3 
Sleep disruption can lead to augmented central pain processing,34 and fatigue is strongly 4 
associated with musculoskeletal pain severity.67 Association between WSP and central 5 
mechanisms has been described previously.10  We extend these findings to show that higher 6 
numbers of painful sites, and pain below the waist other than knee pain, were each 7 
associated with reduced PPT.  A minority of participants in our study satisfied ACR criteria 8 
for WSP and we might have lacked sufficient power to detect associations of WSP with PPT. 9 
However, our data indicate that central mechanisms might still contribute to pain in people 10 
with multisite pain who do not satisfy classification criteria for WSP. 11 
Strength of association between each selected item and PPT was reduced following 12 
adjustment for originating questionnaire derived score, suggesting at least partial mediation 13 
by the host construct. However, associations between PPT and items addressing 14 
neuropathic-like pain in response to cold or heat, or addressing feelings of panic remained 15 
statistically significant even after adjustment for the derived painDETECT and HADS-anxiety 16 
scores. These items might have specific associations with central mechanisms over and 17 
above representing neuropathic-like pain or anxiety respectively.  18 
The ‘central mechanisms’ construct identified here explains slightly more PPT variance than 19 
that explained by any of the individual traits. Association between PPTs and the ‘central 20 
mechanisms’ construct was found to be not explained by originating questionnaire derived 21 
scores, disease- or pain- severity. Together, these findings support use of a composite tool 22 
to identify the extent of central pain augmentation in people with knee pain rather than 23 
individual assessment of each trait on a case-by-case basis in clinical practice. Identification 24 
16 
 
of these central pain mechanisms might well have prognostic relevance, and further work 1 
should assess whether central pain mechanisms might at least in part, explain the predictive 2 
values of other prognostic tools such as the Orebro Musculoskeletal Pain Screening 3 
Questionnaire,44 or StartBACK.38 Items reflecting psychological distress, similar to those 4 
included in the current study, are included within these scales. However, the Orebro and 5 
StartBACK questionnaires do not assess other key traits that we have identified in the 6 
current study, such as somatic traits of neuropathic-like symptoms and pain distribution.  7 
Associations between the ‘central mechanisms’ construct and increased BMI during MIMIC 8 
analysis supports previous work in other chronic pain conditions which demonstrate 9 
significant associations between BMI and other markers of central pain mechanisms.26, 58 10 
Addressing central pain mechanisms using non-pharmacological and/or pharmacological 11 
approaches is likely to improve pain treatment response,  physical function, and other 12 
important outcomes  for the individual.32 Further research should explore whether the core 13 
construct discovered here can predict pain outcome or response to treatment or help 14 
improve healthcare efficiency by directing targeted treatments. Randomized Control Trials 15 
(RCTs) might explore responsiveness of individuals with knee pain to novel or repurposed 16 
pharmacological and non-pharmacological therapies targeted to traits of psychological 17 
distress, neuropathic-like pain and somatic disturbances identified in the current work.21 18 
Longitudinal research might explore whether traits, or the central construct identified in the 19 
current study might predict better treatment response to such centrally targeted 20 
treatments. Conversely, traits identified in this study might indicate a central knee pain 21 
component which might not necessarily respond to a treatment that targets peripheral 22 
nociceptive drive.48 High catastrophizing predicted worse pain improvement after total knee 23 
arthroplasty (TKA) in a previous study.62   24 
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This study is not without its limitations. Participant selection within KPIC for PPT 1 
assessments was weighted towards an early knee pain sample (pain for < 3 years), and a 2 
high proportion had radiographic KL scores <2. Previous studies have demonstrated a lack of 3 
association between PPTs and symptom duration in individuals with OA knee pain,55 but 4 
further research should determine whether our findings can be generalised to people with 5 
longer symptom duration or more severe OA structural change. The traits analysed were 6 
limited to those included within the KPIC baseline survey, and initial screening by the 7 
researchers may have allowed subjective bias during the initial stage of item selection. All 8 
experts involved within the current study originated from a single centre in the UK. Their 9 
breadth of expertise reflected multiple disciplines involved in the treatment and research of 10 
knee pain, but it is possible that additional traits might further contribute to the 11 
identification of pain mechanisms in people with knee pain. The current work is also limited 12 
due to the cross sectional approach employed, and longitudinal studies might help 13 
disentangle the nature of the relationship between pain severity, peripheral pathology, 14 
PPTs, and traits identified in the current study.   15 
We employed only one modality of QST assessment - PPT - which was both employed for 16 
item selection and other validation analysis. PPT has consistently been associated with knee 17 
pain in previous studies and displays good measurement properties in people with knee 18 
pain.53  Our study design selected proximal tibia PPT, distal to the index knee, as a primary 19 
outcome index of central sensitisation. Index knee joint-line PPT displayed higher reliability 20 
than proximal tibia PPT, but is likely to be dependent on peripheral as well as central 21 
sensitization.55 PPTs at remote sites displayed lower reliability than other sites, and are less 22 
strongly associated with OA pain when compared to PPTs from sites distal to the affected 23 
18 
 
joint.55, 73 Further work is needed to confirm the specific central pathways that drive distal 1 
and remote pain sensitivity in knee OA. 2 
Previous work has demonstrated associations between other modalities for accessing 3 
central pain mechanisms (e.g. temporal summation or brain imaging), and self-report 4 
questionnaires about pain distribution, neuropathic-like symptoms, catastrophizing, sleep 5 
disturbance, fatigue, depression and anxiety.1, 9, 13, 17, 45 These other modalities for assessing 6 
central mechanisms, especially those with higher reliability than PPTs, might produce more 7 
confident estimates of associations with the construct identified here.41 8 
Further research should determine whether the central construct identified in the current 9 
study might also predict these other indices of central pain mechanisms. Central 10 
mechanisms and their self-report correlates present across a spectrum, rather than 11 
dichotomous presence or absence, and further research should define clinical thresholds 12 
that might predict or represent important response to treatment.  13 
In conclusion, we show that 8 individual phenotypic traits, as well as a single overall 14 
construct (interpreted as ‘central pain mechanisms’) represented by 8 items, are correlates 15 
of a PPT index for centrally augmented pain in individuals with knee pain. These items might 16 
be combined to identify the extent of central pain augmentation in people with knee pain. 17 
Future research should determine whether a `central pain mechanisms’ questionnaire can 18 
predict prognosis or treatment responses in people who present in a clinical setting with a 19 
local pain problem such as knee pain. 20 
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within the ARUK pain centre for the time and effort they contributed towards the study. 22 
19 
 
This work was supported by Arthritis Research UK (Centre initiative grant number = 20777), 1 
and University of Nottingham as sponsor and host institution. 2 
Conflicts of interest Statement:  3 
Kehinde Akin-Akinyosoye: None declared 4 
Nadia Frowd: None declared 5 
Laura Marshall: None declared 6 
Joanne Stocks: None declared 7 
Gwen Fernandes: None declared 8 
Ana Valdes: None declared 9 
Daniel McWilliams: None declared 10 
Michael Doherty: None declared 11 
Eamonn Ferguson: None declared 12 
Weiya Zhang: 13 
Consultation fees: AstraZeneca (Lesinurad) and Gruenthal (Lesinurad);  14 
Speaker fees: Husin (Chinese Society of Rheumatology Annual Congress 2016) and Bioberica 15 
(EULAR 2016 symposium) in the past 3 years 16 
David Walsh: 17 
Grants from Arthritis Research UK,  during the conduct of the study; grants from Pfizer Ltd, 18 
other from Pfizer Ltd, personal fees from GlaxoSmithKline,  outside the submitted work. 19 
20 
 
REFERENCES  
[1] Akinci A, Al Shaker M, Chang MH, Cheung CW, Danilov A, José Dueñas H, Kim YC, Guillen R, 
Tassanawipas W, Treuer T, Wang Y. Predictive factors and clinical biomarkers for treatment 
in patients with chronic pain caused by osteoarthritis with a central sensitisation 
component. International Journal of Clinical Practice 2016;70(1):31-44. 
[2] Ali A, Lindstrand A, Sundberg M, Flivik G. Preoperative Anxiety and Depression Correlate With 
Dissatisfaction After Total Knee Arthroplasty: A Prospective Longitudinal Cohort Study of 186 
Patients, With 4-Year Follow-Up. The Journal of Arthroplasty 2017;32(3):767-770. 
[3] Allen KD, Bosworth HB, Chatterjee R, Coffman CJ, Corsino L, Jeffreys AS, Oddone EZ, Stanwyck C, 
Yancy WS, Dolor RJ. Clinic variation in recruitment metrics, patient characteristics and 
treatment use in a randomized clinical trial of osteoarthritis management. BMC 
musculoskeletal disorders 2014;15:413. 
[4] Baker PN, van der Meulen JH, Lewsey J, Gregg PJ. The role of pain and function in determining 
patient satisfaction after total knee replacement. Data from the national joint registry for 
England and Wales. Journal of Bone and Joint Surgery - Series B 2007;89(7):893-900. 
[5] Bosma RL, Mojarad EA, Leung L, Pukall C, Staud R, Stroman PW. FMRI of spinal and supra-spinal 
correlates of temporal pain summation in fibromyalgia patients. Human brain mapping 
2016;37(4):1349-1360. 
[6] Brown D, Mulvey M, Cordingley L, Rashid A, Horan M, Pendleton N, Duncan R, McBeth J. The 
relationship between psychological distress and multiple tender points across the adult 
lifespan. Archives of Gerontology and Geriatrics 2016;63:102-107. 
[7] Campbell CM, Buenaver LF, Finan P, Bounds SC, Redding M, McCauley L, Robinson M, Edwards 
RR, Smith MT. Sleep, Pain Catastrophizing, and Central Sensitization in Knee Osteoarthritis 
Patients With and Without Insomnia. Arthritis care & research 2015;67(10):1387-1396. 
[8] Cappelleri JC, Lundy JJ, Hays RD. Overview of Classical Test Theory and Item Response Theory for 
Quantitative Assessment of Items in Developing Patient-Reported Outcome Measures. 
Clinical therapeutics 2014;36(5):648-662. 
[9] Cardoso JS, Riley JL, Glover T, Sibille KT, Bartley EJ, Goodin BR, Bulls HW, Herbert M, Addison AS, 
Staud R, Redden DT, Bradley LA, Fillingim RB, Cruz-Almeida Y. Experimental pain 
phenotyping in community-dwelling individuals with knee osteoarthritis. Pain 
2016;157(9):2104-2114. 
[10] Carlesso L, Neogi T. The association of knee pain and knee osteoarthritis with incident 
widespread pain: The Multicenter Osteoarthritis (MOST) Study. Osteoarthritis and Cartilage 
2016;24, Supplement 1:S193-S194. 
[11] Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H. 
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee 
pain: a 13-week, randomized, placebo-controlled trial. Pain 2009;146(3):253-260. 
[12] Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific 
items: applications to assessment of adaptive behavior. American journal of mental 
deficiency 1981;86(2):127-137. 
[13] Cohen E, Lee YC. A Mechanism-Based Approach to the Management of Osteoarthritis Pain. 
Current osteoporosis reports 2015;13(6):399-406. 
[14] Coronado RA, Simon CB, Valencia C, Parr JJ, Borsa PA, George SZ. Suprathreshold Heat Pain 
Response Predicts Activity-Related Pain, but Not Rest-Related Pain, in an Exercise-Induced 
Injury Model. PloS one 2014;9(9):e108699. 
[15] Croft P, Burt J, Schollum J, Thomas E, Macfarlane G, Silman A. More pain, more tender points: is 
fibromyalgia just one end of a continuous spectrum? Annals of the Rheumatic Diseases 
1996;55(7):482-485. 
[16] Croft P, Jordan K, Jinks C. “Pain elsewhere” and the impact of knee pain in older people. Arthritis 
& Rheumatism 2005;52(8):2350-2354. 
[17] Dave AJ, Selzer F, Losina E, Klara KM, Collins JE, Usiskin I, Band P, Dalury DF, Iorio R, Kindsfater K, 
Katz JN. Is there an association between whole-body pain with osteoarthritis-related knee 
21 
 
pain, pain catastrophizing, and mental health? Clinical orthopaedics and related research 
2015;473(12):3894-3902. 
[18] DiStefano C, Zhu M, Mindrila D. Understanding and using factor scores: Considerations for the 
applied researcher. Practical Assessment, Research & Evaluation 2009;14(20):1-11. 
[19] Doehring A, Küsener N, Flühr K, Neddermeyer TJ, Schneider G, Lötsch J. Effect Sizes in 
Experimental Pain Produced by Gender, Genetic Variants and Sensitization Procedures. PloS 
one 2011;6(3):e17724. 
[20] Eccleston C, Crombez G, Aldrich S, Stannard C. Attention and somatic awareness in chronic pain. 
Pain 1997;72(1–2):209-215. 
[21] Esser S, Bailey A. Effects of Exercise and Physical Activity on Knee Osteoarthritis. Current Pain 
and Headache Reports 2011;15(6):423-430. 
[22] Fernandes GS, Sarmanova A, Warner S, Harvey H, Akin K, Richardson H, Frowd N, Marshall L, 
Stocks J, Hall M, Valdes AM, Walsh D, Zhang W, Doherty M. Knee Pain and Related Health in 
the Community Study (KPIC):  a cohort study protocol. BMC musculoskeletal disorders 
2017;18(104). 
[23] Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, Winter J. Pain 
related behaviour in two models of osteoarthritis in the rat knee. Pain 2004;112(1–2):83-93. 
[24] Finan PH, Buenaver LF, Bounds SC, Hussain S, Park RJ, Haque UJ, Campbell CM, Haythornthwaite 
JA, Edwards RR, Smith MT. Discordance between pain and radiographic severity in knee 
osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis 
and rheumatism 2013;65(2):363-372. 
[25] Fingleton C, Smart K, Moloney N, Fullen BM, Doody C. Pain sensitization in people with knee 
osteoarthritis: a systematic review and meta-analysis. Osteoarthritis and Cartilage 
2015;23(7):1043-1056. 
[26] Fisher DA, Dierckman B, Watts MR, Davis K. Looks Good But Feels Bad: Factors That Contribute 
to Poor Results After Total Knee Arthroplasty. The Journal of Arthroplasty 2007;22(6, 
Supplement):39-42. 
[27] Fleiss JL, Levin B, Paik MC. Statistical Inference for a Single Proportion. Statistical Methods for 
Rates and Proportions: John Wiley & Sons, Inc., 2003. pp. 38-46. 
[28] Flora DB, Flake JK. The purpose and practice of exploratory and confirmatory factor analysis in 
psychological research: Decisions for scale development and validation. Canadian Journal of 
Behavioural Science / Revue canadienne des sciences du comportement 2017;49(2):78-88. 
[29] Frakes EP, Risser RC, Ball TD, Hochberg MC, Wohlreich MM. Duloxetine added to oral 
nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: 
results of a randomized, double-blind, placebo-controlled trial. Current medical research and 
opinion 2011;27(12):2361-2372. 
[30] Goode AP, Shi XA, Gracely RH, Renner JB, Jordan JM. Associations between Pressure-Pain 
Threshold, Symptoms, and Radiographic Knee and Hip Osteoarthritis: The Johnston County 
Osteoarthritis Project. Arthritis care & research 2014;66(10):1513-1519. 
[31] Graven-Nielsen T, Arendt-Nielsen L. Peripheral and central sensitization in musculoskeletal pain 
disorders: an experimental approach. Current rheumatology reports 2002;4(4):313-321. 
[32] Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL. Normalization of 
widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee 
osteoarthritis patients after knee replacement. Arthritis & Rheumatism 2012;64(9):2907-
2916. 
[33] Gwilym SE, Keltner JR, Warnaby CE, Carr AJ, Chizh B, Chessell I, Tracey I. Psychophysical and 
functional imaging evidence supporting the presence of central sensitization in a cohort of 
osteoarthritis patients. Arthritis and rheumatism 2009;61(9):1226-1234. 
[34] Haack M, Scott-Sutherland J, Santangelo G, Simpson N, Sethna N, Mullington JM. Pain Sensitivity 
and Modulation in Primary Insomnia. European journal of pain (London, England) 
2012;16(4):522-533. 
22 
 
[35] Hadlandsmyth K, Sabic E, Zimmerman MB, Sluka KA, Herr KA, Clark CR, Noiseux NO, Callaghan JJ, 
Geasland KM, Embree JL, Rakel BA. Relationships among pain intensity, pain-related distress, 
and psychological distress in pre-surgical total knee arthroplasty patients: a secondary 
analysis. Psychology, Health & Medicine 2017;22(5):552-563. 
[36] Harden RN, Bruehl S, Stanos S, Brander V, Chung OY, Saltz S, Adams A, Stulberg SD. Prospective 
examination of pain-related and psychological predictors of CRPS-like phenomena following 
total knee arthroplasty: a preliminary study. Pain 2003;106(3):393-400. 
[37] Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Katz JN, 
Dieppe P. Development and preliminary psychometric testing of a new OA pain measure--an 
OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008;16(4):409-414. 
[38] Hill JC, Dunn KM, Lewis M, Mullis R, Main CJ, Foster NE, Hay EM. A primary care back pain 
screening tool: Identifying patient subgroups for initial treatment. Arthritis care & research 
2008;59(5):632-641. 
[39] Hochman JR, Gagliese L, Davis AM, Hawker GA. Neuropathic pain symptoms in a community 
knee OA cohort. Osteoarthritis and Cartilage 2011;19(6):647-654. 
[40] Lacey RJ, Lewis M, Jordan K, Jinks C, Sim J. Interrater reliability of scoring of pain drawings in a 
self-report health survey. Spine 2005;30(16):E455-458. 
[41] Lachin JM. The role of measurement reliability in clinical trials. Clinical trials (London, England) 
2004;1(6):553-566. 
[42] Lee YC, Nassikas NJ, Clauw DJ. The role of the central nervous system in the generation and 
maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. 
Arthritis Research & Therapy 2011;13(2):211. 
[43] Liao JJ, Lewis JW. A note on concordance correlation coefficient. PDA journal of pharmaceutical 
science and technology 2000;54(1):23-26. 
[44] Linton SJ, Hallden K. Can we screen for problematic back pain? A screening questionnaire for 
predicting outcome in acute and subacute back pain. Clin J Pain 1998;14(3):209-215. 
[45] Lluch E, Nijs J, Courtney CA, Rebbeck T, Wylde V, Baert I, Wideman TH, Howells N, Skou ST. 
Clinical descriptors for the recognition of central sensitization pain in patients with knee 
osteoarthritis. Disabil Rehabil 2017:1-10. 
[46] Lluch Girbes E, Duenas L, Barbero M, Falla D, Baert IA, Meeus M, Sanchez-Frutos J, Aguilella L, 
Nijs J. Expanded Distribution of Pain as a Sign of Central Sensitization in Individuals With 
Symptomatic Knee Osteoarthritis. Phys Ther 2016;96(8):1196-1207. 
[47] Marfeo EE, Ni P, Chan L, Rasch EK, Jette AM. Combining agreement and frequency rating scales 
to optimize psychometrics in measuring behavioral health functioning. Journal of clinical 
epidemiology 2014;67(7):781-784. 
[48] Martinez V, Fletcher D, Bouhassira D, Sessler DI, Chauvin M. The evolution of primary 
hyperalgesia in orthopedic surgery: Quantitative sensory testing and clinical evaluation 
before and after total knee arthroplasty. Anesthesia and Analgesia 2007;105(3):815-821. 
[49] Moreton BJ, Tew V, das Nair R, Wheeler M, Walsh DA, Lincoln NB. Pain Phenotype in Patients 
With Knee Osteoarthritis: Classification and Measurement Properties of painDETECT and 
Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs Scale in a Cross‐Sectional 
Study. Arthritis care & research 2015;67(4):519-528. 
[50] Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: A review of clinical 
and preclinical research. Progress in Neurobiology 2011;93(3):385-404. 
[51] Moss P, Knight E, Wright A. Subjects with Knee Osteoarthritis Exhibit Widespread Hyperalgesia 
to Pressure and Cold. PloS one 2016;11(1):e0147526. 
[52] Muthén M. MPLUS: Version 7.4. Los Angeles, CA, 2012. 
[53] Mutlu EK, Ozdincler AR. Reliability and responsiveness of algometry for measuring pressure pain 
threshold in patients with knee osteoarthritis. Journal of Physical Therapy Science 
2015;27(6):1961-1965. 
23 
 
[54] Neblett R, Cohen H, Choi Y, Hartzell MM, Williams M, Mayer TG, Gatchel RJ. The Central 
Sensitization Inventory (CSI): establishing clinically significant values for identifying central 
sensitivity syndromes in an outpatient chronic pain sample. J Pain 2013;14(5):438-445. 
[55] Neogi T, Frey-Law L, Scholz J, Niu J, Arendt-Nielsen L, Woolf C, Nevitt M, Bradley L, Felson DT. 
Sensitivity and sensitisation in relation to pain severity in knee osteoarthritis: trait or state? 
Ann Rheum Dis 2015;74(4):682-688. 
[56] Neugebauer V, Lucke T, Schaible HG. N-methyl-D-aspartate (NMDA) and non-NMDA receptor 
antagonists block the hyperexcitability of dorsal horn neurons during development of acute 
arthritis in rat's knee joint. Journal of neurophysiology 1993;70(4):1365-1377. 
[57] O'Connor S, Ferguson E, Carney T, House E, O'Connor RC. The development and evaluation of 
the paediatric index of emotional distress (PI-ED). Social psychiatry and psychiatric 
epidemiology 2016;51(1):15-26. 
[58] Okifuji A, Hare BD. The association between chronic pain and obesity. Journal of Pain Research 
2015;8:399-408. 
[59] Petersen KK, Arendt-Nielsen L, Simonsen O, Wilder-Smith O, Laursen MB. Presurgical 
assessment of temporal summation of pain predicts the development of chronic 
postoperative pain 12 months after total knee replacement. Pain 2015;156(1):55-61. 
[60] Petersen KK, Graven-Nielsen T, Simonsen O, Laursen MB, Arendt-Nielsen L. Preoperative pain 
mechanisms assessed by cuff algometry are associated with chronic postoperative pain relief 
after total knee replacement. Pain 2016;157(7):1400-1406. 
[61] Reilly SC, Muir KR, Doherty M. Screening for pain in knee osteoarthritis: which question? Annals 
of the Rheumatic Diseases 1996;55(12):931. 
[62] Riddle DL, Wade JB, Jiranek WA, Kong X. Preoperative Pain Catastrophizing Predicts Pain 
Outcome after Knee Arthroplasty. Clinical orthopaedics and related research 
2010;468(3):798-806. 
[63] Sagar DR, Staniaszek LE, Okine BN, Woodhams S, Norris LM, Pearson RG, Garle MJ, Alexander 
SPH, Bennett AJ, Barrett DA, Kendall DA, Scammell BE, Chapman V. Tonic Modulation of 
Spinal Hyperexcitability by the Endocannabinoid Receptor System in a Rat Model of 
Osteoarthritis Pain. Arthritis and rheumatism 2010;62(12):3666-3676. 
[64] Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 
2002;966:343-354. 
[65] Sirri L, Grandi S, Fava GA. The Illness Attitude Scales. A clinimetric index for assessing 
hypochondriacal fears and beliefs. Psychotherapy and psychosomatics 2008;77(6):337-350. 
[66] Skou ST, Graven-Nielsen T, Lengsoe L, Simonsen O, Laursen MB, Arendt-Nielsen L. Relating 
clinical measures of pain with experimentally assessed pain mechanisms in patients with 
knee osteoarthritis. Scandinavian Journal of Pain 2013;4(2):111-117. 
[67] Snijders GF, van den Ende CHM, Fransen J, van Riel PLCM, Stukstette MJPM, Defoort KC, Arts-
Sanders MA, van den Hoogen FHJ, den Broeder AA. Fatigue in knee and hip osteoarthritis: 
the role of pain and physical function. Rheumatology 2011;50(10):1894-1900. 
[68] Somers TJ, Keefe FJ, Pells JJ, Dixon KE, Waters SJ, Riordan PA, Blumenthal JA, McKee DC, LaCaille 
L, Tucker JM, Schmitt D, Caldwell DS, Kraus VB, Sims EL, Shelby RA, Rice JR. Pain 
catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and 
disability. Journal of pain and symptom management 2009;37(5):863-872. 
[69] Soni A, Mezue M, Wanigasekera V, Javaid M, Price AJ, Tracey I. Neuroimaging evidence of 
central sensitization in patients with knee osteoarthritis. Osteoarthritis and Cartilage 
2016;24(Supplement 1):S443. 
[70] StataCorp. Stata Statistical Software: Release 14.2. College Station, TX: StataCorp LP, 2015. 
[71] Sullivan M, Tanzer M, Stanish W, Fallaha M, Keefe FJ, Simmonds M, Dunbar M. Psychological 
determinants of problematic outcomes following Total Knee Arthroplasty. Pain 2009;143(1-
2):123-129. 
[72] Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. 
Psychological Assessment 1995;7(4):524-532. 
24 
 
[73] Suokas AK, Walsh DA, McWilliams DF, Condon L, Moreton B, Wylde V, Arendt-Nielsen L, Zhang 
W. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-
analysis. Osteoarthritis Cartilage 2012;20(10):1075-1085. 
[74] Thomas KS, Muir KR, Doherty M, Jones AC, Reilly SC, Bassey EJ. Home based exercise 
programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ 
2002;325(7367):752. 
[75] Villemure C, Bushnell MC. Mood Influences Supraspinal Pain Processing Separately from 
Attention. The Journal of Neuroscience 2009;29(3):705. 
[76] Walton DM, Levesque L, Payne M, Schick J. Clinical Pressure Pain Threshold Testing in Neck Pain: 
Comparing Protocols, Responsiveness, and Association With Psychological Variables. 
Physical Therapy 2014;94(6):827-837. 
[77] Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, 
Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria 
for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis 
and rheumatism 1990;33(2):160-172. 
[78] Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain 
2011;152(SUPPL.3):S2-S15. 
[79] Wylde V, Beswick AD, Dennis J, Gooberman-Hill R. Post-operative patient-related risk factors for 
chronic pain after total knee replacement: a systematic review. BMJ open 2017;7(11). 
[80] Wylde V, Hewlett S, Learmonth ID, Dieppe P. Persistent pain after joint replacement: 
prevalence, sensory qualities, and postoperative determinants. Pain 2011;152(3):566-572. 
[81] Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica 
Scandinavica 1983;67(6):361-370. 
25 
 
FIGURE 
 
Figure 1. Flow chart showing the item selection process across traits.  
 
ESEM = Exploratory Structural Equation Modelling. # Only relevant for items  originating from established questionnaires measuring specific traits.  
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TABLES 
 
Table 1. Baseline demographics and clinical characteristics of participants with knee pain 
 
 
 
 
 
 
 
 
 
 
 
Data are median (interquartile ranges, IQR) except where indicated. Gender, age, Body Mass Index (BMI) and geometric mean of log-transformed pressure 
pain detection thresholds (PPT) are given for all 322 cases. Questionnaire data are presented where complete data available (constant-Intermittent and 
Constant Osteoarthritis Pain scale (ICOAP) n=280; intermittent-ICOAP n=296; Anxiety-Hospital Anxiety and Depression scale (HADS) n=315; Depression-
HADS n=314; Pain Catastrophizing Scale, PCS, n = 314; Modified PainDETECT Questionnaire n=282).
 
knee pain sample 
p Overall  
(n = 322) 
Exploratory 
(n = 168) 
Confirmatory 
(n = 154) 
Gender; n (%) female 197 (61%) 99 (50%) 98 (50%) 0.38 
Age; mean ± SD years 59.4 ± 9.5 59.9 ± 9.7 59.9 ± 9.8 0.98 
BMI; mean ± SD kg/m
2 29.5 ± 6.1 29.3 ±5.6 30.0 ± 6.5 0.30 
Proximal tibia PPT (kPA) 372 (265 – 528) 391 (268 – 523) 361 (249 – 528) 0.96 
Tibiofemoral KL>=2; n (%)  96 (30%) 55 (33%) 41 (27%) 0.22 
Questionnaire Scores 
 
   
Constant pain-ICOAP (possible range 0 – 24) 6 (3 – 11) 6 (3 – 11) 6 (3 – 12) 0.75 
Intermittent pain-ICOAP (possible range 0 – 22) 8 (5 – 14) 8 (5 – 14) 9 (5 – 14) 0.94 
Modified PainDETECT (possible range -1 – 38) 9 (5 – 14) 9 (5 – 14) 9 (5 – 14) 0.56 
Pain Catastrophizing Scale (possible range 0 – 52) 8 (3 – 20) 8 (3 – 20) 8 (3 – 19) 0.83 
Anxiety-HADS (possible range 0 – 14) 6 (4 – 10) 6 (4 – 9) 7 (4 – 10) 0.09 
Depression-HADS (possible range 0 – 14) 5 (3 – 8) 4 (3 – 8) 5 (3 – 8) 0.78 
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Table 2. Pressure pain detection thresholds (PPT) at the proximal tibia are predicted by 
ROC- and a priori- binary manikin classifications in individuals within the knee pain sample 
(n=322). 
 
Classifications are based on number or distribution of painful sites in addition to knee pain 
reported by participants on a body manikin. ROC; receiver-operating curve. 
aWidespread pain;  classified according to American College of Rheumatology criteria37, 
including knee pain.  
Bold indicates statistically significant associations.  
Proportion (n, %) of participants with knee pain reporting other pain according to 
classifications are presented.  
Unstandardized (b) and standardized (β) regression coefficients are presented 
 n (%) b (95% CI) β p 
ROC-Derived Classifications     
≥5/7 other sites 62 (19%) -0.20 (-0.37 to -0.03) -0.14 0.02 
≥6/23 other sites 86 (27%) -0.19 (-0.34 to -0.04) -0.14 0.01 
A priori Classifications     
Above waist 189 (59%) -0.08 (-0.22 to -0.06) -0.07 0.26 
Below waist 169 (52%) -0.17 (-0.30 to -0.03) -0.14 0.02 
Contralateral to index knee 119 (37%) -0.14 (-0.28 to 0.002) -0.12 0.05 
Axial pain 151 (47%) -0.01 (-0.15 to 0.12) -0.01 0.87 
Widespread paina 31 (10%) -0.08 (-0.34 to 0.18) -0.03 0.55 
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Table 3. Item performance for each statistical criteria to select “best performing items” across traits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Items in bold represent items selected as “best performing items”. *p<0.05 (Bonferroni corrected).  
#Items presented (items = 19) were rated by experts to show relevance to centrally augmented mechanisms following expert rating (k*>0.60).  
Items originating from established scales showed the highest significant (p<0.05) associations with each identified latent construct during ESEM analysis. Domains measured by singular items (item specific domains) not entered into 
ESEM. 
Hospital Anxiety and Depression scale (HADS); Modified PainDETECT Questionnaire (MPDQ); Pain Catastrophizing Scale (PCS), Intermittent and Constant Osteoarthritis Pain (ICOAP) scale.  
Fatigue, Pain Distribution and Cognitive Impact measured by singular items. 
 
Shortlisted Items (items = 19)# Traits Scale - ESEM construct (loading score) Expert rating  (k*) Respondents 
endorsing scores >0 
(%) 
Correlation with log-
PPTs (Spearman’s 
rho)  
1. "I look forward with enjoyment to things" Depression 
 
HADS - Depression (0.93) 
 
0.71 
 
54% 
 
-0.12* 
2. "I still enjoy the things I used to enjoy" Depression HADS -Depression (0.82) 0.64 75% -0.15* 
3. "I can’t seem it keep it out of my mind" Catastrophic thinking PCS - Rumination (0.92) 0.71 52% -0.11 
4. "I keep thinking about how much it hurts" Catastrophic thinking PCS - Rumination (1.08) 0.83 59% -0.13* 
5. “I feel I can’t go on” Catastrophic thinking PCS - Helplessness (0.99) 0.78 24% -0.09 
6. “I feel I can’t stand it anymore” Catastrophic thinking PCS - Helplessness (0.93) 0.78 56% -0.09 
7. Is cold or heat (bath water) in this area 
occasionally painful? Neuropathic Symptoms MPDQ - Evoked  symptoms (0.85) 0.73 43% -0.23* 
8. Over the past month, in your most painful knee, is 
light touching (clothing, a blanket) in this area 
painful? Neuropathic Symptoms MPDQ - Evoked  symptoms (0.56) 0.79 40% -0.21* 
9. Over the past month, do you have a tingling or 
prickling sensation in the area of your most 
painful knee ‘pain’ (like crawling ants or electrical 
tingling)? Neuropathic Symptoms MPDQ - Spontaneous symptoms (1.15) 0.66 50% -0.09 
10. In the past week, how much has your knee pain 
that comes and goes affected your sleep? Intermittent  pain experience 
Intermittent ICOAP - Somatic 
symptoms (0.71) 0.64 56% -0.17* 
11. In the past week, how upset or worried have you 
been by your knee pain that comes and goes? Intermittent  pain experience 
Intermittent ICOAP - Psychological 
symptoms (0.76) 0.69 71% -0.14* 
12. In the past week, how frustrated or annoyed have 
you been by your constant knee pain? Constant pain experience 
Intermittent ICOAP - Psychological 
symptoms (0.78) 0.60 76% -0.17* 
13. In the past week, how upset or worried have you 
been by your constant knee pain? Constant pain experience 
Constant ICOAP - Psychological 
symptoms (0.90) 0.78 69% -0.16* 
14. In the past week, how much has your constant 
knee pain affected your sleep? Constant pain experience 
Constant ICOAP - Somatic symptoms 
(0.88) 0.78 68% -0.21* 
15. "I get a sort of frightened feeling as if something 
awful is about to happen" Anxiety HADS -Anxiety (0.83) 0.69 60% -0.08 
16. "I get sudden feelings of panic" Anxiety HADS -Anxiety (0.82) 0.61 53% -0.19* 
17. Knee pain plus other pain below the waist Pain Distribution - 0.81 52% -0.14* 
18. Does your pain or other bodily symptoms stop 
you from concentrating on what you are doing? Cognitive Impact - 0.71 74% -0.18* 
19. In the past month, did you feel tired on most 
days? Fatigue - 0.61 96% -0.15* 
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Table 4. Standardized item loadings for the 8 selected items in a single factor model in 
exploratory and confirmatory subgroups.
*p<0.05 
Item Domain Exploratory 
sample 
(n=166) 
Confirmatory 
sample (n=154) 
"I get sudden feelings of panic" Anxiety 0.53* 0.49* 
"I still enjoy the things I used to enjoy" Depression 0.57* 0.52* 
“Over the past month, in your most painful 
knee, is cold or heat (bath water) in this area 
occasionally painful?” 
Neuropathic 
symptoms 0.52* 0.57* 
 “In the past month, did you feel tired on 
most days?” 
Fatigue 
0.62* 0.61* 
 “Does your pain or other bodily symptoms 
stop you from concentrating on what you 
are doing?” 
Attention to 
pain 0.79* 0.81* 
 “Knee pain plus other pain below waist” Pain 
distribution 
0.44* 0.40* 
"I keep thinking about how much it hurts" Catastrophising 0.57* 0.58* 
 “In the past week, how much has your 
constant knee pain affected your sleep?” 
Sleep 
0.66* 0.69* 
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Table 5. Prediction of proximal tibia PPT by identified factor independent of derived host 
scale scores (host scale score minus selected items score 
 
 
 
 
 
 
 
 
The single latent construct identified through the 8 selected items, interpreted as `central 
mechanisms of knee pain’, was associated with log transformed pressure pain detection thresholds 
(PPT) distal (Proximal tibia) from the index knee in an unadjusted model, and in models where total 
scores derived from each of the originating scales (scale summary score minus selected item) were 
adjusted for.  
Standardized coefficients (β) presented. 
 
 
 
 
 
 
 
 
 
Scales adjusted for β S.E p 
Unadjusted Model -0.27 0.07 <0.001 
Constant Pain - ICOAP -0.19 0.07 0.01 
Neuropathic Pain - PainDETECT -0.21  0.07 0.01 
Catastrophizing - PCS -0.28 0.08 <0.001 
Anxiety - HADS -0.24 0.07 0.001 
Depression - HADS -0.26 0.08 0.001 
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SUPPLEMENTARY INFORMATION 
Supplementary Table 1. Inter- and intra- observer agreement for pressure pain detection threshold (PPT) assessments 
 
 
 
 
 
 
 
List of assessors:  Laura Marshall (LM), Nadia Frowd (NF).   
Abbreviations: CCC – concordance correlation coefficient, CI – confidence interval, PPT – pain pressure thresholds, n=number of participants assessed 
 
 
 Inter-observer agreement Intra-observer agreement 
Anatomical site Observers n CCC (95% C.I.) Observers n CCC (95% C.I.) 
Proximal tibia NF-LM 8 0.51 (-0.01 to 1.02) LM 8 0.60 (0.28 to 0.92) 
Sternum NF-LM 8 0.61 (0.17 to 1.05) LM 9 0.39 (-0.13 to 0.91) 
Medial Joint Line NF-LM 8 0.75 (0.43 to 1.07) LM 8 0.90 (0.76 to 1.05) 
Lateral Joint Line NF-LM 8 0.86 (0.68 to 1.03) LM 8 0.61 (0.10 to 1.13) 
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Supplementary Table 2: Standardized item loading for the Hospital Anxiety and Depression Scale 
(HADS) two factor model. 
Fit statistics for two factor model: CFI = 0.985; TLI=0.979; RMSEA = 0.073; WRMR = 3.127; X2(df) = 
220 (64). 
Items in bold represents the two highest loading items within each identified factor. 
* p<0.05 **p<0.01 *** p<0.001 
 
 
Items Factor 1 
(Depression) 
Factor 2 
(Anxiety) 
1. I feel tense or wound up 0.245*** 0.603*** 
2. I still enjoy the things I used to enjoy 0.840*** 0.177** 
3. I get a sort of frightened feeling as if something awful is 
about to happen 
0.004 0.836*** 
4. I can laugh and see the funny side of things 0.759*** 0.054 
5. Worrying thoughts go through my mind 0.045 0.816*** 
6. I feel cheerful 0.739*** 0.074 
7. I can sit at ease and feel relaxed 0.629*** 0.205*** 
8. I feel as if I am slowed down 0.129 0.226*** 
9. I get a sort of frightened feeling like ‘butterflies’  in the 
stomach 
0.092 0.484*** 
10. I have lost interest in my appearance 0.592*** 0.008 
11. I feel restless as if I have to be on the move 0.112* 0.419*** 
12. I look forward with enjoyments to things 0.943*** -0.109 
13. I get sudden feelings of panic 0.031 0.868*** 
14. I can enjoy a good book or radio or television programme 0.591*** 0.028 
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Supplementary Table 3: Standardized item loading for the Pain Catastrophizing Scale (PCS) two 
factor model. 
Fit statistics for two factor model: CFI = 0.998; TLI=0.997; RMSEA = 0.043; WRMR = 1.183; X2(df) = 
253 (53) 
Items in bold represents the two highest loading items within each identified factor. 
* p<0.05 **p<0.01 *** p<0.001 
 
 
 
 
 
 
 
Items 
Factor 1 
(Helplessness) 
Factor 2 
(Rumination) 
1. I worry all the time about whether the pain will end 0.470*** 0.395*** 
2. I feel I can‘t go on 1.000*** 0.131* 
3. It’s terrible and I think it’s never going to get any better 0.858*** 0.074 
4. It’s awful and I feel that it overwhelms me 0.871*** 0.101** 
5. I feel I can’t stand it anymore 0.932*** 0.001 
6. I become afraid that the pain will get worse 0.495*** 0.384*** 
7. I keep thinking of other painful events 0.460*** 0.361*** 
8. I anxiously want the pain to go away 0.069 0.814*** 
9. I can’t seem it keep it out of my mind 0.000 0.921*** 
10. I keep thinking about how much it hurts 0.169*** 1.097*** 
11. I keep thinking about how badly I want the pain to stop 0.041 0.901*** 
12. There’s nothing I can do to reduce the intensity of the 
pain 
0.310*** 0.542*** 
13. I wonder whether something serious may happen 0.240** 0.519*** 
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Supplementary Table 4: Standardized item loading for the PainDETECT (PDQ) three factor model. 
 
Items 
Factor 1  
(Pain 
Intensity) 
 
Factor 2 
(Spontaneous 
Neuropathic- 
Like pain)  
Factor 3 
(Evoked 
Neuropathic- 
Like pain) 
1. Over the past month, does your pain run up and 
down your leg? 
0.218*** 0.424*** 0.033 
2. How would you rate your most painful knee pain 
on a 0-10 scale at the present time, that is right 
now, where 0 is ‘no pain’ and 10 is ‘pain as bad as 
could be’? 
0.664*** 0.063 0.109* 
3. In the past month. How intense was your worst 
knee pain rated on a 0-10 scale, where 0 is ‘no 
pain’ and 10 is ‘pain as bad as could be’? 
0.926*** 0.006 0.005  
4. In the past month, on average, how intense was 
the pain in your most painful knee rated on a 0-
10 scale, where 0 is ‘no pain’ and 10 is ‘pain as 
bad as could be’? 
0.959*** 0.005 0.023 
5. The next question is on the pattern of your pain in 
your most painful knee. Which of the 4 different 
options below is the one that best describes the 
pattern of your worst knee pain over the past 
month? 
-0.283*** 0.043 0.273 
6. Do you suffer from a burning sensation (e.g., 
stinging nettles) in or around your most painful 
knee? 
0.100* 
 
0.710*** 0.007*** 
7. Do you have a tingling or prickling sensation in 
the area of your most painful knee ‘pain’ (like 
crawling ants or electrical tingling)? 
0.001 1.153*** 0.226* 
8. Is light touching (clothing, a blanket) in this area 
painful? 
0.149** 0.191*** 0.559*** 
9. Do you have sudden pain attacks in the area of 
your pain, like electric shocks? 
0.237*** 0.240*** 0.177** 
10. Is cold or heat (bath water) in this area 
occasionally painful? 
0.001 0.002 0.861*** 
11. Do you suffer from a sensation of numbness in the 
areas that you marked? 
0.102* 0.400*** 0.361*** 
12. Does slight pressure in this area, e.g., with a 
finger, trigger pain? 
0.152 0.001 0.520*** 
Fit statistics for two factor model: CFI = 0.987; TLI=0.974; RMSEA = 0.038; WRMR = 0.54; X2(df) = 
65.41 (33) 
Items in bold represents the two highest loading items within each identified factor. 
* p<0.05 **p<0.01 *** p<0.001 
  
35 
 
 
Supplementary Table 5: Standardized item loading for the Constant pain ICOAP two factor model. 
 
 
Items 
Factor 1  
(Somatic effects of 
constant pain) 
 
Factor 2 
(Psychological 
effects of 
constant pain)  
1. In the past week, how intense has your constant 
knee pain been?  
0.797* 0.165 
2. In the past week, how much has your constant 
knee pain affected your sleep?  
0.888* 0.005 
3. In the past week, how much has your constant 
knee pain affected your overall quality of life?  
0.417* 0.552* 
4. In the past week, how frustrated or annoyed 
have you been by your constant knee pain?  
0.184 0.780* 
5. In the past week, how upset or worried have you 
been by your constant knee pain?  
0.006 0.940* 
Fit statistics for two factor model: CFI = 1.00; TLI=1.00; RMSEA = 0.014; WRMR = 0.106; X2(df) = 1.15 
(1) 
Items in bold represents the two highest loading items within each identified factor. 
*p < 0.001 
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Supplementary Table 6: Standardized item loading for the Intermittent pain ICOAP two factor 
model. 
 
 
Items 
Factor 1  
(Somatic effects of 
constant pain) 
Factor 2 
(Psychological effects 
of constant pain)  
1. In the past week, how intense has your knee 
pain that comes and goes been? 
0.967** 0.003 
2. In the past week, how much has your knee pain 
that comes and goes affected your sleep? 
0.709** 0.246* 
3. In the past week, how much has your knee pain 
that comes and goes affected your overall quality 
of life? 
0.485** 0.380** 
4. In the past week, how frustrated or annoyed have 
you been by your knee pain that comes and goes? 
0.379** 0.601** 
5. In the past week, how upset or worried have you 
been by your knee pain that comes and goes? 
0.215* 0.758** 
6. In the past week, how frequently has this knee 
pain that comes and goes occurred? 
0.006 0.964** 
Fit statistics for two factor model: CFI = 1.00; TLI=0.99; RMSEA = 0.06; WRMR = 0.353; X2(df) = 15.8 
(4) 
Items in bold represents the two highest loading items within each identified factor. 
* p<0.05** p < 0.001
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Supplementary Table 7. Responses from participants with knee pain to items selected as relevant to central pain mechanisms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are median (interquartile ranges, IQR).
Domains Items 
knee pain sample 
p Overall  
(n = 322) 
Exploratory 
(n = 168) 
Confirmatory 
(n = 154) 
Anxiety I get sudden feelings of panic  (possible range 0 to 3) 1 (0 to 1) 1 (0 to 1) 1 (0 to 1) 0.204 
I get a sort of frightened feeling as if something awful is about to 
happen  ( possible range 0 to 3) 
1 (0 to 2) 1 (0 to 2) 1 (0 to 2) 0.199 
Depression I still enjoy the things I used to enjoy (possible range 0 to 3) 1 (0 to 1) 1 (0 to 1) 1 (1 to 1) 0.887 
I look forward with enjoyments to things (possible range 0 to 3) 1 (0 to 1) 1 (0 to 1) 1 (0 to 1) 0.746 
Neuropathic- 
like pain 
Do you have a tingling or prickling sensation in the area of your 
most painful knee ‘pain’ (like crawling ants or electrical tingling)?    
(possible range 0 to 5) 
1 (0 to 2) 0 (0 to 2) 1 (0 to 2) 0.991 
Is light touching (clothing, a blanket) in this area painful?  
(possible range 0 to 5) 
0 (0 to 1) 0 (0 to 1) 0 (0 to 2) 0.832 
Is cold or heat (bath water) in this area occasionally painful? 
(possible range 0 to 5) 
0 (0 to 1) 0 (0 to 1) 0 (0 to 1) 0.984 
Fatigue In the past month, did you feel tired on most days? 
(possible range 0 to 5) 
2 (2 to 3) 2 (2 to 3) 2 (2 to 3) 0.352 
Cognitive 
Impact 
Does your pain or other bodily symptoms stop you from 
concentrating on what you are doing? (possible range 0 to 4) 
1 (0 to 2) 2 (1 to 2) 1 (0 to 2) 0.481 
Pain 
Distribution 
Other pain below waist (possible range 0 to 1) 1 (0 to 1) 1 (0 to 1) 1 (0 to 1) 0.793 
Pain 
Catastrophizing 
I feel I can’t stand it anymore (possible range 0 to 4) 0 (0 to 1) 0 (0 to 1) 0 (0 to 1) 0.359 
I feel I can‘t go on (possible range 0 to 4) 0 (0 to 0) 0 (0 to 1) 0 (0 to 0) 0.415 
I can’t seem it keep it out of my mind (possible range 0 to 4) 1 (0 to 2) 1 (0 to 2) 1 (0 to 1) 0.423 
I keep thinking about how much it hurts (possible range 0 to 4) 1 (0 to 2) 1 (0 to 2) 1 (0 to 2) 0.788 
Constant pain 
experience 
In the past week, how much has your constant knee pain affected 
your sleep?  (possible range 0 to 4) 
1 (0 to 2) 1 (0 to 2) 1 (0 to 2) 0.504 
In the past week, how frustrated or annoyed have you been by 
your constant knee pain?  (possible range 0 to 4) 
1 (1 to 3) 1 (1 to 3) 2 (0 to 3) 0.792 
In the past week, how upset or worried have you been by your 
constant knee pain?  (possible range 0 to 4) 
1 (0 to 2) 1 (0 to 2) 1 (0 to 2) 0.651 
Intermittent  
pain experience 
In the past week, how much has your knee pain that comes and 
goes affected your sleep? (possible range 0 to 4) 
1 (0 to 2) 1 (0 to 2) 1 (0 to 2) 0.915 
In the past week, how upset or worried have you been by your 
knee pain that comes and goes? (possible range 0 to 4) 
1 (0 to 2) 1 (0 to 2) 1 (0 to 2) 0.229 
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Supplementary Table 8. Associations between self-report measures. 
 
 
ICOAP (Intermittent and Constant Osteoarthritis Pain), HADS (Hospital Anxiety and Depression 
scale), PCS (Pain Catastrophizing Scale). Data from participants with knee pain (n=322). Data are 
Spearman correlation coefficients using untransformed total scale scores. *P<0.05 
 
 
 
 
 
 Neuropathic- 
like pain – 
painDETECT 
Constant 
Pain - ICOAP 
Intermittent 
pain - ICOAP 
Depression 
-HADS 
Anxiety -
HADS 
 
Constant Pain – ICOAP 0.63* - - - - 
Intermittent pain – 
ICOAP 
0.62* 0.62* - - - 
Depression – HADS 0.39* 0.43* 0.32* - - 
Anxiety- HADS 0.33* 0.30* 0.23* 0.57* - 
Pain Catastrophizing - 
PCS 
0.50* 0.57* 0.47* 0.57* 0.58* 
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Supplementary Table 9. Inter-item correlation matrix for 19 items putatively reflecting central mechanisms in people with knee pain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Full item texts were the same as given in Supplementary Table 7. Data are Spearman correlation coefficients from participants with knee pain (n=322). *p<0.05.  
 
 
 
 
 
Domains  Anxiety Depression Neuropathic- like pain Fatigue Cognitive 
Impact 
Pain 
Distribution 
Pain Catastrophizing Constant pain experience Intermittent  
pain experience 
 
Items Fright Panic Still 
enjoy 
Look 
forward 
Tingling Light 
touch 
Cold 
heat 
Tired Concentrate 
on pain 
Other pain 
below waist 
Can’t 
stand it 
Can’t 
go on 
Out of 
mind 
Keep 
thinking 
Sleep Frustrate Upset Sleep 
Anxiety Panic 0.66* 1.00 - - - - - - - - - - - - - - - - 
Depression Still enjoy 0.19* 0.20* 1.00 - - - - - - - - - - - - - - - 
Look forward 0.32* 0.28* 0.56* 1.00 - - - - - - - - - - - - - - 
Neuropathic- 
like pain 
Tingling 0.24* 0.20* 0.27* 0.20* 1.00 - - - - - - - - - - - - - 
Light touch 0.22* 0.29* 0.26* 0.23* 0.51* 1.00 - - - - - - - - - - - - 
Cold/heat 0.21* 0.20* 0.25* 0.26* 0.47* 0.65* 1.00 - - - - - - - - - - - 
Fatigue Tired 0.41* 0.39* 0.33* 0.37* 0.23* 0.31* 0.33* 1.00 - - - - - - - - - - 
Cognitive 
Impact 
Concentrate 
on pain 
0.35* 0.33* 0.41* 0.38* 0.38* 0.41* 0.37* 0.44* 1.00 - - - - - - - - - 
Pain 
Distribution 
Other pain 
below waist 
0.11 0.07 0.21* 0.24* 0.07 0.19* 0.13* 0.18* 0.29* 1.00 - - - - - - - - 
Pain 
Catastrophizing 
Can’t stand it 0.41* 0.34* 0.35* 0.43* 0.42* 0.29* 0.33* 0.36* 0.49* 0.11 1.00  - - - - - - 
Can’t go on 0.40* 0.32* 0.37* 0.44* 0.36* 0.31* 0.33* 0.32* 0.42* 0.11 0.67* 1.00 - - - - - - 
Out of mind 0.46* 0.40* 0.28* 0.44* 0.39* 0.33* 0.35* 0.38* 0.44* 0.17* 0.69* 0.53* 1.00 - - - - - 
Keep thinking 0.44* 0.39* 0.22* 0.41* 0.35* 0.38* 0.34* 0.33* 0.42* 0.19* 0.71* 0.51* 0.78* 1.00 - - - - 
Constant pain 
experience 
Sleep 0.17* 0.19* 0.27* 0.29* 0.45* 0.53* 0.51* 0.35* 0.48* 0.26* 0.44* 0.32* 0.41* 0.43* 1.00 - - - 
Frustrate 0.22* 0.18* 0.36* 0.32* 0.49* 0.42* 0.45* 0.35* 0.47* 0.24* 0.52* 0.36* 0.50* 0.48* 0.67* 1.00 - - 
Upset 0.26* 0.26* 0.31* 0.32* 0.49* 0.41* 0.41* 0.32* 0.45* 0.20* 0.47* 0.37* 0.51* 0.49* 0.60* 0.87* 1.00 - 
Intermittent  
pain experience 
Sleep 0.24* 0.26* 0.26* 0.30* 0.48* 0.53* 0.48* 0.33* 0.46* 0.26* 0.46* 0.33* 0.42* 0.44* 0.85* 0.63* 0.59* 1.00 
Upset 0.26* 0.26* 0.29* 0.33* 0.49* 0.37* 0.42* 0.31* 0.45* 0.21* 0.48* 0.39* 0.53* 0.51* 0.50* 0.78* 0.87* 0.54* 
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Supplementary Table 10. Associations between selected items and proximal tibia pressure pain detection threshold (PPT) are dependent on 
constructs measured by their host questionnaires. 
In order to explore whether observed univariate associations between each selected item and proximal tibia log-PPTs might be explained by the 
construct measured by the host scale from the host scale from which it originated, we adjusted each univariate association for the derived host 
scale score (scale summary score minus selected item). Data are from participants with knee pain sample (n=322). Bold indicates significant 
associations after adjustment. Unstandardized (b) and standardized coefficients (β) are presented. 
 
 
 
 
 
 Unadjusted model Adjusted model   
Domains b (95% CI) β p b (95% CI) β p 
Constant Pain Experience 
“In the past week, how much has your constant 
knee pain affected your sleep?” 
-0.11 (-0.17 to -0.04) -0.21 0.001 -0.08 (-0.17 to 0.02) -0.15 0.119 
Neuropathic- like pain 
“Over the past month, in your most painful 
knee, is cold or heat (bath water) in this area 
occasionally painful?” 
-0.10 (-0.17 to -0.05) -0.23 <0.001 -0.10 (-0.17 to -0.03) -0.21 0.008 
Catastrophizing 
"I keep thinking about how much it hurts" 
-0.06 (-0.12 to -0.01) -0.13 0.03 0.004 (-0.12 to 0.12) 0.007 0.953 
Anxiety 
"I get sudden feelings of panic" 
-0.13 (-0.21 to -0.05) -0.19 0.001 -0.12 (-0.24 to -0.01) -0.19 0.032 
Depression 
"I still enjoy the things I used to enjoy" 
-0.10 (-0.18 to -0.02) -0.15 0.01 -0.06 (-0.16 to 0.04) -0.09 0.252 
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Supplementary Table 11: PPTs at sites other than the proximal tibia are predicted by ROC- derived and a priori- binary manikin 
classifications in individuals within the knee pain sample (n=322) 
Classifications are based on number or distribution of painful sites in addition to knee pain reported by participants on a body manikin. aWidespread pain;  
classified according to American College of Rheumatology criteria37, including knee pain. Bold indicates statistically significant associations. ROC; receiver-
operating curve. Log-transformed pressure pain detection thresholds (PPT) at (medial or lateral tibiofemoral joint line (JL), or remote (sternum) from the 
index knee reported here.  Data utilized from knee pain sample (n=322). Unstandardized (b) and standardized (β) regression coefficients are presented.   
 
 
 
 
 
 
 
 
Sternum Med JL Lat JL 
b (95% CI) β p b (95% CI) β p b (95% CI) β p 
Roc-Derived Classifications          
≥5/7 other sites -0.20 (-0.37 to -0.03) -0.18 0.002 -0.24 (-0.39 to -0.09) -0.15 0.011 -0.29 (-0.47 to -0.12) -0.19 0.001 
≥6/23 other sites -0.19 (-0.34 to -0.04) -0.14 0.019 -0.16 (-0.30 to -0.03) -0.14 0.018 -0.21 (-0.36 to -0.05) -0.15 0.010 
A priori Classifications          
Above waist -0.08 (-0.22 to -0.06) -0.05 0.430 -0.05 (-0.17 to 0.07) -0.08 0.205 -0.08 (-0.22 to 0.06) -0.07 0.266 
Below waist -0.17 (-0.30 to -0.03) -0.16 0.007 -0.27 (-0.42 to -0.12) -0.21 0.001 -0.22 (-0.36 to -0.08) -0.18 0.002 
Contralateral to index knee -0.14 (-0.28 to 0.002) -0.08 0.165 -0.18 (-0.34 to 0.03) -0.14 0.021 -0.12 (-0.27 to 0.02) -0.09 0.100 
Axial pain -0.01 (-0.15 to 0.12) -0.05 0.441 -0.08 (-0.23 to 0.07) -0.06 0.318 -0.07 (-0.21 to 0.07) -0.06 0.309 
ACR’s Widespread paina -0.10 (-0.34 to 0.14) -0.05 0.407 -0.09 (-0.39 to 0.20) -0.04 0.533 0.01 (-0.22 to 0.25) 0.007 0.910 
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Supplementary Table 12. Associations between latent construct `Central mechanisms’ and PPTs for sites other than proximal tibia within the 
knee pain sample (n=322) 
 
 
 
 
 
 
The single latent construct identified through the 8 selected items, interpreted as `central mechanisms of knee pain’, was associated with log-transformed 
pressure pain detection thresholds (PPT) at (medial or lateral tibiofemoral joint line (JL), or remote (sternum) from the index knee in an unadjusted model, and in 
models where total scores derived from each of the originating scales (scale summary score minus selected item) were adjusted for.  
Standardized regression coefficients (β) presented. 
 
 
 
 
 
 
Scales adjusted for Sternum Medial JL Lateral JL 
β S.E P β S.E P β  S.E  P 
Unadjusted Model -0.25 0.06 <0.001 -0.41 0.06 <0.001 -0.39 0.06 <0.001 
Constant Pain experience - ICOAP -0.22 0.07 0.001 -0.32 0.06 <0.001 -0.29 0.07 <0.001 
Neuropathic- like pain - PainDETECT -0.22 0.06 0.001 -0.31 0.07 <0.001 -0.30 0.07 <0.001 
Catastrophizing - PCS -0.21 0.07 0.003 -0.38 0.07 <0.001 -0.34 0.07 <0.001 
Anxiety - HADS -0.20 0.07 0.003 -0.37 0.06 <0.001 -0.35 0.06 <0.001 
Depression - HADS -0.19 0.07 0.008 -0.42 0.07 <0.001 -0.37 0.07 <0.001 
